Catalyst OrthoScience closed $20M funding round

Catalyst OrthoScience Inc. closed $20 million in equity and venture debt financing. The funding partners included RC Capital, Mutual Capital Partners, and Bridge Bank. This financing coincided with the company surpassing 10,000 total shoulder arthroplasty (TSA) procedures.

The company intends to use the funds to expand its distribution channel, further invest in talent and training, and launch new products. Catalyst OrthoScience focuses on shoulder arthroplasty, aiming to provide innovative solutions that improve efficiency and patient outcomes, particularly as procedures shift to ambulatory surgery centers. The investment is expected to support the company's next stage of commercial adoption and solidify its position in the shoulder arthroplasty market.